The White House launches TrumpRx, a platform for the direct sale of medications

Washington.- The White House launched this Thursday TrumpRx, a direct-to-consumer drug sales platform that the President Donald Trump Administration presented as one of its main bets to reduce the cost of prescription drugs in the United States. “We are here tonight to celebrate the launch of one of the most transformative healthcare initiatives of all time. There has never been anything like it,” Trump stated during the presentation of the platform, held in Washington. According to the president, TrumpRx will function as a portal that will directly connect patients with pharmaceutical companies willing to sell certain medications to people who pay in cash and forgo health insurance, as explained by the White House.

We recommend reading:Teacher awarded as ‘Teacher of the Year’ accused of three cases of child sexual abuse

The TrumpRx platform seeks reduced prices

The initiative seeks to offer reduced prices by eliminating intermediaries in the distribution chain. Among the medications available through this system are some of the most demanded on the market, including the anti-obesity drugs Zepbound and Wegovy, which can be purchased at a discount through direct agreements with the manufacturers. The platform is a central pillar of Trump’s strategy to supposedly contain the high cost of prescription drugs. The Administration maintains that TrumpRx will expand options for consumers, although experts and healthcare industry groups have pointed out that its impact will depend on the number of pharmaceutical companies that join the program and the actual scope of the discounts offered. This platform emerged from the Republican wing amid a dispute over the approval of Obamacare, the Affordable Care Act (ACA), approved in 2010 by the Barack Obama administration, which generated legislative dispute in 2025 between both parties.